Leading vaccine makers are under investor scrutiny as Robert F. Kennedy Jr., a notable vaccine skeptic and President Donald Trump’s nominee to lead the Department of Health and Human Services (HHS), ...
Follow the market action on Wednesday to see whether the post-DeepSeek rally can continue and how investors react to the ...
The Federal Reserve is widely expected to make no change to its benchmark federal funds rate at its January meeting, a ...
We recently compiled a list of the 7 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where The ...
We recently compiled a list of the 7 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where PENN ...
We recently compiled a list of the 7 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where ...
Boeing's focus on core values and product-driven turnaround under CEO Kelly Ortberg offers promising long-term potential.
Investing.com - Healthcare and vaccine stocks are likely to be in the spotlight on Wednesday as Robert F. Kennedy Jr., U.S. President Donald Trump's pick to run the Department of Health and Human ...
Eyck Freymann is a Hoover Fellow at Stanford University and Nonresident Research Fellow with the China Maritime Studies ...
U.S. stock indexes are holding steadier, ahead of the Federal Reserve’s upcoming decision on interest rates and after two ...
U.S. stock indexes were mostly lower on Wednesday morning ahead of the release of the Federal Reserve's first monetary-policy decision of the year. The Dow Jones Industrial Average was flat, trading ...
He cited inflation running above the Fed's 2% target, the expanding economy and a "solid" U.S. labor market. Before cutting rates again, the central bank may need to see "a couple months of some ...